CN102284017A - Chinese medicinal preparation for reducing hypertension - Google Patents

Chinese medicinal preparation for reducing hypertension Download PDF

Info

Publication number
CN102284017A
CN102284017A CN2011102314989A CN201110231498A CN102284017A CN 102284017 A CN102284017 A CN 102284017A CN 2011102314989 A CN2011102314989 A CN 2011102314989A CN 201110231498 A CN201110231498 A CN 201110231498A CN 102284017 A CN102284017 A CN 102284017A
Authority
CN
China
Prior art keywords
parts
medicinal preparation
chinese medicinal
reducing
blood pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011102314989A
Other languages
Chinese (zh)
Inventor
王双
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TANGSHAN KANGJIAN BIOLOGICAL TECHNOLOGY Co Ltd
Original Assignee
TANGSHAN KANGJIAN BIOLOGICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TANGSHAN KANGJIAN BIOLOGICAL TECHNOLOGY Co Ltd filed Critical TANGSHAN KANGJIAN BIOLOGICAL TECHNOLOGY Co Ltd
Priority to CN2011102314989A priority Critical patent/CN102284017A/en
Publication of CN102284017A publication Critical patent/CN102284017A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a Chinese medicinal preparation for reducing hypertension. The Chinese medicinal preparation comprises the following raw materials in part by weight: 300 to 500 parts of apocynum venetum, 150 to 300 parts of tall gastrodia tuber, 400 to 500 parts of lycium bark, 700 to 800 parts of mulferry root bark, 500 to 600 parts of sophora flower, 300 to 400 parts of siberian solomonseal rhizome, 400 to 600 parts of hawthorn fruit and 50 to 70 parts of auxiliary materials, wherein the raw materials are prepared into capsules. On the basis of a large number of experiments, the Chinese medicinal preparation is prepared by screening high-quality Chinese herbal medicines such as the tall gastrodia tuber, the apocynum venetum and the like from plant medicines according to the scientific blood pressure-reducing Chinese medicine theory of 'reducing blood pressure and regulating blood fat, nourishing heart and brain and protecting liver and kidney'. The Chinese medicinal preparation has the effects of reducing blood pressure and blood fat, is convenient to take and satisfactory in a curative effect and does not have toxic or side effect.

Description

A kind of Chinese medicine preparation of antihypertensive
Technical field
The present invention relates to the Chinese medicine preparation of the medicine of blood pressure lowering, particularly a kind of antihypertensive, belong to traditional Chinese medical science pharmaceutical technology field.
Background technology
The hypertension prevalence has been remarkable growth trend in China, and it is to cause important organs impaired " arch-criminal " such as the heart, brain, kidney, finally can cause the nonfunction of these internal organs, and human physical and mental health in serious threat.Present domestic ACEI hypotensor thing etc. is classified as a line antihypertensive drugs by World Health Organization (WHO) and China's " hypertension therapeutic guide ", but being one or two people, one of side effect causes zest dry cough after taking, can be with dry pharynx, itching throat, uncomfortable in chest, night and the flat postemphasis of crouching, erythra, pruritus, dysgeusia, albuminuria, granulocyte perhaps occurring lacks, neutrophilic leukocyte reduces, the renal artery stenosis person, heart failure, coronary artery or cerebral arteriosclerosis patient must careful usefulness.No matter Macrolide is oral or intravenously administrable, prolonged application or dosage are excessive and cause hepatic injury, all can cause kidneys poison reactions such as albuminuria, hematuria, and Auditory nerve impairment is caused deafness, and person in middle and old age are outstanding easily takes place, and still can continue sometimes to increase the weight of after drug withdrawal.Sulfonamides can cause hematuria, urine retention, renal tubules pathological changes, renal function injury, and also cocoa causes granulocytopenia, leukopenia.
Summary of the invention
The invention discloses a kind of Chinese medicine preparation of antihypertensive, stablize blood pressure lowering, transfer blood fat, without any side effects.
The present invention is according to " reducing blood pressure and regulating blood lipid, brain hepatoprotective kidney nourishes heart " science blood pressure lowering theory of Chinese medical science.And from plant amedica, screen high-quality natural Chinese medicinal herb such as Rhizoma Gastrodiae, Herba Apocyni veneti and develop.Have the function that brings high blood pressure down with blood fat, taking convenience, satisfactory effect, without any side effects.
The invention belongs to the oral formulations of Chinese medicine preparation, be mixed with capsule, tablet, granule, pill in an amount of ratio, its component is that Herba Apocyni veneti, Rhizoma Gastrodiae, Cortex Lycii, Cortex Mori, Flos Sophorae, Rhizoma Polygonati, Fructus Crataegi are raw material,
Medicine of the present invention is the Chinese medicine preparation of being made by ratio of weight and the number of copies by following material:
Herba Apocyni veneti 300-500, Rhizoma Gastrodiae 150-300, Cortex Lycii 400-500, Cortex Mori 700-800, Flos Sophorae 500-600, Rhizoma Polygonati 300-400, Fructus Crataegi 400-600, adjuvant 50-70.
Optimum ratio of the present invention is:
Herba Apocyni veneti 400 Rhizoma Gastrodiaes 150 Cortex Lycii 450 Cortex Mori 800 Flos Sophoraes 550
Rhizoma Polygonati 350 Fructus Crataegis 500 adjuvants 55
Technical process
(1) pre-treatment
1, clean: Herba Apocyni veneti, Cortex Lycii, Cortex Mori, Flos Sophorae, Rhizoma Polygonati, Fructus Crataegi clean respectively, choose non-medicinal parts such as the removal of impurity.
2, cutting, drying: wash profit, cutting respectively, drying after Herba Apocyni veneti, Cortex Lycii, Cortex Mori, Flos Sophorae, Rhizoma Polygonati, the Fructus Crataegi selection; The gastrodia liquor profit, cutting, drying.
3, pulverize: dry back Rhizoma Gastrodiae is ground into 100 order micropowders, and is standby.
(2) extraction concentrates
1, batching: accurately take by weighing each medical material respectively by batch inventory.
2, extraction concentrates: with Herba Apocyni veneti, Cortex Lycii, Cortex Mori, Flos Sophorae, Rhizoma Polygonati, the Fructus Crataegi medical material that takes by weighing, dipping, decoct with water 2 times, for the first time add 10 times of water gagings, decocted 8 hours, add 8 times of water gagings for the second time, decocted 6 hours, collecting decoction filters, and receives cream (80 ℃) when filtrate is concentrated into relative density for 1.30-1.40.
3, drying: the extractum of collection carries out drying in 80 ℃.
4, pulverize: dry back extract powder is broken into into 100 order micropowders, and is standby.
(3) preparation process:
1, batching: accurately take by weighing required medicated powder respectively by batch inventory.
2, mix: the medicated powder that weighs up is put in the mixer mixed 30 minutes.
3, fill polishing: will mix powder according to mixed powder with capsule filling machine and be filled in the Capsules, and polish with buffing machine.
4, packing, packing.
The specific embodiment
It is as follows that example 1. above-mentioned raw material of Chinese medicine are pressed the prescription profile instance:
Herba Apocyni veneti 400 Rhizoma Gastrodiaes 150 Cortex Lycii 450 Cortex Mori 800 Flos Sophoraes 550 Rhizoma Polygonatis 350 Fructus Crataegis 500 adjuvants 55
Preparation method
1, clean: Herba Apocyni veneti, Cortex Lycii, Cortex Mori, Flos Sophorae, Rhizoma Polygonati, Fructus Crataegi clean respectively, choose non-medicinal parts such as the removal of impurity.
2, cutting, drying: wash profit, cutting respectively, drying after Herba Apocyni veneti, Cortex Lycii, Cortex Mori, Flos Sophorae, Rhizoma Polygonati, the Fructus Crataegi selection; The gastrodia liquor profit, cutting, drying.
3, pulverize: dry back Rhizoma Gastrodiae is ground into 100 order micropowders, and is standby.
4, batching: accurately take by weighing each medical material respectively by batch inventory.
5, extraction concentrates: with Herba Apocyni veneti, Cortex Lycii, Cortex Mori, Flos Sophorae, Rhizoma Polygonati, the Fructus Crataegi medical material that takes by weighing, dipping, decoct with water 2 times, for the first time add 10 times of water gagings, decocted 8 hours, add 8 times of water gagings for the second time, decocted 6 hours, collecting decoction filters, and receives cream (80 ℃) when filtrate is concentrated into relative density for 1.30-1.40.
6, drying: the extractum of collection carries out drying in 80 ℃.
7, pulverize: dry back extract powder is broken into into 100 order micropowders, and is standby.
8, preparation batching: accurately take by weighing required medicated powder respectively by batch inventory.
9, mix: the medicated powder that weighs up is put in the mixer mixed 30 minutes.
10, fill polishing: will mix powder according to mixed powder with capsule filling machine and be filled in 1000 Capsuleses, and polish with buffing machine.
11, packing, packing.

Claims (2)

1. the Chinese medicine preparation of an antihypertensive is characterized in that being being made by the raw material of following weight portion: Herba Apocyni veneti 300-500, Rhizoma Gastrodiae 150-300, Cortex Lycii 400-500, Cortex Mori 700-800, Flos Sophorae 500-600, Rhizoma Polygonati 300-400, Fructus Crataegi 400-600, adjuvant 50-70.
2. Chinese medicine preparation according to claim 1 is characterized in that it being that raw material by following weight portion is made: Herba Apocyni veneti 400, Rhizoma Gastrodiae 150, Cortex Lycii 450, Cortex Mori 800, Flos Sophorae 550, Rhizoma Polygonati 350, Fructus Crataegi 500, adjuvant 55.
CN2011102314989A 2011-08-15 2011-08-15 Chinese medicinal preparation for reducing hypertension Pending CN102284017A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011102314989A CN102284017A (en) 2011-08-15 2011-08-15 Chinese medicinal preparation for reducing hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011102314989A CN102284017A (en) 2011-08-15 2011-08-15 Chinese medicinal preparation for reducing hypertension

Publications (1)

Publication Number Publication Date
CN102284017A true CN102284017A (en) 2011-12-21

Family

ID=45330953

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102314989A Pending CN102284017A (en) 2011-08-15 2011-08-15 Chinese medicinal preparation for reducing hypertension

Country Status (1)

Country Link
CN (1) CN102284017A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103651982A (en) * 2013-11-22 2014-03-26 安徽大平油脂有限公司 Health oil with efficacy of lowering blood pressure
CN104490186A (en) * 2014-10-31 2015-04-08 冀明 Traditional Chinese medicine pillow with function of reducing blood pressure
CN104906403A (en) * 2015-07-07 2015-09-16 青岛恒波仪器有限公司 Folium apocyni veneti health oral liquid capable of decreasing blood pressure and lipid and preparation method thereof
CN107823329A (en) * 2017-11-15 2018-03-23 合肥学院 Treat Chinese medicine composition of hypertension and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102048961A (en) * 2009-11-09 2011-05-11 景松森 Traditional Chinese medicine preparation for treating hypertension

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102048961A (en) * 2009-11-09 2011-05-11 景松森 Traditional Chinese medicine preparation for treating hypertension

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
公国睿等: "黄精益阴汤治疗老年高血压病的临床观察", 《河北中医》, vol. 32, no. 11, 30 November 2010 (2010-11-30) *
梁纪文等: "高血压病的中医辩证及验方治疗", 《中国临床医生》, vol. 38, no. 10, 31 December 2010 (2010-12-31) *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103651982A (en) * 2013-11-22 2014-03-26 安徽大平油脂有限公司 Health oil with efficacy of lowering blood pressure
CN104490186A (en) * 2014-10-31 2015-04-08 冀明 Traditional Chinese medicine pillow with function of reducing blood pressure
CN104490186B (en) * 2014-10-31 2016-02-24 马霞 A kind of Chinese medicinal pillow with hypotensive activity
CN104906403A (en) * 2015-07-07 2015-09-16 青岛恒波仪器有限公司 Folium apocyni veneti health oral liquid capable of decreasing blood pressure and lipid and preparation method thereof
CN107823329A (en) * 2017-11-15 2018-03-23 合肥学院 Treat Chinese medicine composition of hypertension and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101708295B (en) Chinese medicinal preparation for treating diabetes and preparation methods thereof
CN101273745B (en) Health care tea for moistening intestines
CN101862413B (en) Chinese medicinal preparation for treating type-2 diabetes and preparation method thereof
CN101721563A (en) Three high rehabilitation tea
CN102178867B (en) Chinese medicine preparation for replenishing qi to invigorate spleen and tonifying kidney and products thereof
CN104435775A (en) Chinese medicinal health-care spirit and preparation method thereof
CN101912484A (en) Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia
CN101596295B (en) Medicinal composition for treating gout and preparation process thereof
CN102293273A (en) Health tea capable of adjusting blood pressure, blood sugar and blood fat and preventing thrombus and apoplexy
CN104587441A (en) Cardiovascular disease regulating traditional Chinese medicine composition and preparation method thereof
CN101249175B (en) Chinese medicine prescription for curing myopic eye disease and production method of preparations
CN102284017A (en) Chinese medicinal preparation for reducing hypertension
CN102973719A (en) Traditional Chinese medicine health-care food with bowel relaxing function and preparation method thereof
CN101011562B (en) Novel formulation of shenqiwendan decoction and production method thereof
CN102949481A (en) Health care tea for reducing blood pressure and blood lipid
CN101559152A (en) Chinese materia medica preparation for treating hydrocephalus and preparation method thereof
CN101406598B (en) Chinese medicine composite for treating diabetes and preparation method thereof
CN108042766A (en) A kind of Bushen Tongluo supports brain cream and preparation method thereof
CN101085121A (en) Traditional Chinese medicine composition with hypoglycemic and antilipemic function and making method and application
CN106309736B (en) Anti-fatigue Chinese medicinal composition and its preparation method and application
CN101869663B (en) Chinese medicinal preparation for treating diabetes and preparation method thereof
CN101658627A (en) Granules for tranquillization
CN104096073A (en) Traditional Chinese medicine composition for treating male infertility and preparation method for same
CN103933282A (en) Traditional Chinese medicine preparation for treating diabetes
CN103599211B (en) A kind of pharmaceutical composition for the treatment of diabetes and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20111221